Status:
UNKNOWN
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes
Lead Sponsor:
Adistem Ltd
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
16-60 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether intravenous administration of autologous adipose stem cells is safe and beneficial in patients with type 1 diabetes.
Detailed Description
Diabetes Mellitus is of large epidemic proportions worldwide. It is proliferating at such a fast rate that new novel drugs and other therapeutic approaches are required. The purpose of this Phase I/II...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Type I diabetes for at least 2 years
- Insulin-dependent
Exclusion
- Presence of acute diabetic complications in the acute stage as recent myocardial infarction, recent CVA or acute renal failure.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00703599
Start Date
November 1 2007
End Date
December 1 2009
Last Update
July 1 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beverly Hills Medical Group
Makati City, Manila, Philippines
2
Veterens Memorial Medical Centre
Quezon City, Manila, Philippines, 1229